A study of amsalog (CI-921) administered orally on a 5-day schedule, with bioavailability and pharmacokinetically guided dose escalation. (Record no. 11763992)

MARC details
000 -LEADER
fixed length control field 01640 a2200481 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250514024127.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200203s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0344-5704
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/s00280-001-0389-z
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Fyfe, D
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20020308
245 00 - TITLE STATEMENT
Title A study of amsalog (CI-921) administered orally on a 5-day schedule, with bioavailability and pharmacokinetically guided dose escalation.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer chemotherapy and pharmacology
Date of publication, distribution, etc. Jan 2002
300 ## - PHYSICAL DESCRIPTION
Extent 1-6 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Comparative Study; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Administration, Oral
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Amsacrine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Area Under Curve
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biological Availability
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dose-Response Relationship, Drug
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Injections, Intravenous
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Raynaud, F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Langley, R E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Newell, D R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Halbert, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gardner, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Clayton, K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Woll, P J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Judson, I
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Carmichael, J
773 0# - HOST ITEM ENTRY
Title Cancer chemotherapy and pharmacology
Related parts vol. 49
-- no. 1
-- p. 1-6
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/s00280-001-0389-z">https://doi.org/10.1007/s00280-001-0389-z</a>
Public note Available from publisher's website

No items available.